Current Paradigms of Tolerogenic Dendritic Cells and Clinical Implications for Systemic Lupus Erythematosus
Tolerogenic dendritic cells (tolDCs) are central players in the initiation and maintenance of immune tolerance and subsequent prevention of autoimmunity. Recent advances in treatment of autoimmune diseases including systemic lupus erythematosus (SLE) have focused on inducing specific tolerance to av...
Main Authors: | Patcharee Ritprajak, Chamraj Kaewraemruaen, Nattiya Hirankarn |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-10-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/8/10/1291 |
Similar Items
-
Introducing the tolerogenic macrophage therapy as an alternative approach to manage systemic lupus erythematosus: a case series
by: Terawan Agus Putranto, et al.
Published: (2019-12-01) -
The generation of tolerogenic dendritic cells in SLE and study of their mechanisms of action and therapeutic application in a lupus mouse model
by: Wu, Haijing, et al.
Published: (2014) -
Regulating Immunogenicity and Tolerogenicity of Bone Marrow-Derived Dendritic Cells through Modulation of Cell Surface Glycosylation by Dexamethasone Treatment
by: Kevin Lynch, et al.
Published: (2017-10-01) -
Ethyl Pyruvate Induces Tolerogenic Dendritic Cells
by: Neda Djedovic, et al.
Published: (2019-02-01) -
Tolerogenic Dendritic Cells: The Pearl of Immunotherapy in Organ Transplantation
by: Quan Zhuang, et al.
Published: (2020-10-01)